Affordability of New Technologies: The Next Frontier
- PMID: 29566829
- DOI: 10.1016/j.jval.2018.01.011
Affordability of New Technologies: The Next Frontier
Similar articles
-
Transparency of economic evaluations of health technologies.Pharmacoeconomics. 2008;26(3):181-3. doi: 10.2165/00019053-200826030-00002. Pharmacoeconomics. 2008. PMID: 18282013 No abstract available.
-
Improving the usefulness of budget impact analyses: a U.S. payer perspective.Value Health. 2014 Jan-Feb;17(1):3-4. doi: 10.1016/j.jval.2013.09.007. Value Health. 2014. PMID: 24438711 No abstract available.
-
Cost effective but unaffordable: an emerging challenge for health systems.BMJ. 2017 Mar 22;356:j1402. doi: 10.1136/bmj.j1402. BMJ. 2017. PMID: 28330879 No abstract available.
-
Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.Value Health. 2007 Sep-Oct;10(5):336-47. doi: 10.1111/j.1524-4733.2007.00187.x. Value Health. 2007. PMID: 17888098
-
A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.J Am Coll Radiol. 2008 Nov;5(11):1125-9. doi: 10.1016/j.jacr.2008.06.008. J Am Coll Radiol. 2008. PMID: 18954812 Review.
Cited by
-
Long-term Survival and Value of Chimeric Antigen Receptor T-Cell Therapy for Pediatric Patients With Relapsed or Refractory Leukemia.JAMA Pediatr. 2018 Dec 1;172(12):1161-1168. doi: 10.1001/jamapediatrics.2018.2530. JAMA Pediatr. 2018. PMID: 30304407 Free PMC article.
-
Understanding Payer Perspectives on Value in the Use of Pharmaceuticals in the United States.J Manag Care Spec Pharm. 2019 Dec;25(12):1319-1327. doi: 10.18553/jmcp.2019.25.12.1319. J Manag Care Spec Pharm. 2019. PMID: 31778613 Free PMC article.
-
The ethics of aggregation in cost-effectiveness analysis or, "on books, bookshelves, and budget impact".Front Health Serv. 2022 Oct 13;2:889423. doi: 10.3389/frhs.2022.889423. eCollection 2022. Front Health Serv. 2022. PMID: 36925796 Free PMC article.
-
Critical Reflections on Reimbursement and Access of Advanced Therapies.Front Pharmacol. 2022 May 18;13:771966. doi: 10.3389/fphar.2022.771966. eCollection 2022. Front Pharmacol. 2022. PMID: 35662719 Free PMC article.
-
Complicated legacies: The human genome at 20.Science. 2021 Feb 5;371(6529):564-569. doi: 10.1126/science.abg5266. Epub 2021 Feb 4. Science. 2021. PMID: 33542123 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources